Q1 2017

Filed Jun 8, 2017 · 10-Q · 39 days after period end · 0001697884-17-000018

Q1 2017 · 10-Q

Revenue

$6.12K

no prior Q1 2016 on file

Net Income

-$1.10K

no prior Q1 2016 on file

EPS Diluted

$0.00

no prior Q1 2016 on file

Gross Profit$5,152—

Operating Cash Flow

Same quarter

no prior Q1 2016 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Apr 30, 2017 · filed Jun 8, 2017 · 39 d after period end

Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR

VSBCVitaspring Biomedical Co. Ltd.

Filed Jun 8, 2017 · 10-Q · 39 days after period end · 0001697884-17-000018

Q1 2017 · 10-Q

Revenue

$6.12K

no prior Q1 2016 on file

Net Income

-$1.10K

no prior Q1 2016 on file

EPS Diluted

$0.00

no prior Q1 2016 on file

Gross Profit$5,152—

Operating Cash Flow

no prior Q1 2016 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Apr 30, 2017 · filed Jun 8, 2017 · 39 d after period end

Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR